日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer

通过克隆和同型选择设计的抗体药物偶联物可抑制表达CSPG4的三阴性乳腺癌的生长。

Esapa, Benjamina; Liu, Yi; Chenoweth, Alicia M; Stoker, Katie; Łabędź, Natalia; Romero-Clavijo, Pablo; Ilieva, Kristina M; Trendell, Jennifer; Navarro-Llinas, Blanca; Suriawinata, Erin; Butcher, Tobias; Wang, Ning; Grandits, Melanie; Palhares, Lais C G F; McCraw, Alexandra; Crescioli, Silvia; Johansson, Annelie; Irshad, Sheeba; Grigoriadis, Anita; Gazinska, Patrycja; Tsoka, Sophia; Chudasama, Vijay; Baker, James R; Tutt, Andrew N J; Cheung, Anthony; Thurston, David E; Karagiannis, Sophia N

Melanoma/CSPG4-Enhanced Collagen-Mediated Contact Guidance Requires Mutant Active BRAF and the CSPG4 Core Protein Cytoplasmic Domain

黑色素瘤/CSPG4增强的胶原介导的接触引导需要突变活性BRAF和CSPG4核心蛋白胞质结构域。

Thrivikraman, G; Yang, J; Price, M; Giubellino, A; McCarthy, J B; Tranquillo, R T

CSPG4 Mediates Inflammatory, Cell Death, and Senescence Responses in Enteric Glia Exposed to Clostridioides difficile Toxins.

CSPG4介导肠神经胶质细胞暴露于艰难梭菌毒素时的炎症、细胞死亡和衰老反应。

Marques Francisco M S, Costa Deiziane V S, Rebouças Conceição S M, Brito Gerly A C, Warren Cirle A, Leitão Renata F C

Clostridioides difficile TcdB induces expression of its receptor (CSPG4) through a noncanonical Hippo signaling mechanism.

艰难梭菌TcdB通过非经典Hippo信号机制诱导其受体(CSPG4)的表达。

Larabee Jason L, Donald Elizabeth J, Sukhadia Anushka A, Shadid Tyler M, Miller Sarah J, Ballard Jimmy D

CSPG4(+) extracellular vesicles carry fibronectin and interleukin-11 and reflect radiographic severity in knee osteoarthritis

CSPG4(+)细胞外囊泡携带纤连蛋白和白细胞介素-11,并反映膝骨关节炎的放射学严重程度。

Zhang, Xin; MacFarlane, Lindsey Adair; Huebner, Janet L; Tao, Jason Jinkun; Katz, Jeffrey Neil; Kraus, Virginia Byers

Identification of CSPG4 as a Biomarker and Therapeutic Target for Infantile Post-Hemorrhagic Hydrocephalus via Multi-Omics Analysis

通过多组学分析鉴定CSPG4为婴儿出血后脑积水的生物标志物和治疗靶点

Chen, Juncao; Wang, Lin; Peng, Xiangwen; Cheng, Tingting; Yang, Yihui; Su, Jingzhen; Zou, Hongmei; Wang, Siyao; Mao, Yueting; Wu, Lixiang; Yin, Xuntao; Li, Minxu; Zhu, Mingwei; Zhou, Wei

B7-H3 and CSPG4-targeted CAR T cells as potent effectors in anaplastic thyroid cancer

靶向B7-H3和CSPG4的CAR T细胞作为间变性甲状腺癌的有效效应细胞

Giulia Cattaneo ,Marco Ventin ,Shahrzad Arya ,Cedric Bailey ,Venkata Rao Vantaku ,Jingyu Jia ,Maoyang Qi ,Luke Maggs ,Xinhui Wang ,Sareh Parangi ,Soldano Ferrone ,Cristina R Ferrone

Human CSPG4-targeting CAR-macrophages inhibit melanoma growth

靶向人CSPG4的CAR-巨噬细胞抑制黑色素瘤生长

Greiner, Daniel; Xue, Qian; Waddell, Trinity Qa; Kurudza, Elena; Chaudhary, Piyush; Belote, Rachel L; Dotti, Gianpietro; Judson-Torres, Robert L; Reeves, Melissa Q; Cheshier, Samuel H; Roh-Johnson, Minna

Preclinical Evaluation of (68)Ga-Labeled CSPG4-Targeting Peptides for PET/CT Imaging in Pancreatic and Gastric Carcinoma

胰腺癌和胃癌PET/CT成像中(68)Ga标记的CSPG4靶向肽的临床前评价

Wang, Zerong; Pan, Xiaoyu; Li, Ye; Zhang, Fengsheng; Bian, Linjie; Li, Jindian

Clinical evaluation of HuDo-CSPG4 DNA electroporation as adjuvant treatment for canine oral malignant melanoma: comparison of two vaccination protocols

HuDo-CSPG4 DNA电穿孔作为犬口腔恶性黑色素瘤辅助治疗的临床评价:两种疫苗接种方案的比较

Camerino, Mariateresa; Giacobino, Davide; Tarone, Lidia; Dentini, Alfredo; Martano, Marina; Morello, Emanuela; Ferraris, Erica Ilaria; Manassero, Luca; Iussich, Selina; Maniscalco, Lorella; Cavallo, Federica; Riccardo, Federica; Buracco, Paolo